Expert Insights

Peptide Protocol: How to Build One (2026 Guide)

A peptide protocol is a plan, not just a compound. Here's how to actually build one - compound, dose, frequency, cycle length, and how to track it - with sample templates by goal.

August 25, 2026 11 min read By Dave Belmonte, Founder
Peptide Protocol Dosing Cycling Beginner Guide
Back to Expert Insights

A peptide protocol is a plan for using one or more peptides toward a specific goal. It has four parts: which compound, what dose, how often, and how long before a break. Taking BPC-157 is not a protocol. Taking 500mcg twice a day for six weeks, tracked, with a clear stop point, is.

Most people land on this page after reading about one peptide and needing the rest of the picture: how much, how often, and how to know it's working. That's what this guide covers. For the science on a specific compound, see the Peptide Encyclopedia. For exact syringe math, see the Dosage Calculator. To build and track your own protocol, use the Protocol Builder.

The 5 Core Components of Every Protocol

Every protocol comes down to the same five decisions. Get these right and the rest is detail work.

Component What it determines Common mistake
Compound selection Which peptide(s) actually match the stated goal Choosing a compound because it's popular, not because it fits the goal
Dose How much per administration, usually in mcg or mg Copying someone else's dose without adjusting for bodyweight or goal
Frequency Once daily, twice daily, every other day, or weekly Inconsistent timing, which makes it impossible to judge whether it's working
Cycle length How many weeks on before a scheduled break Running indefinitely with no defined stop point
Tracking A record of dose, timing, and subjective response over time Not tracking at all, so there's no way to attribute effects to the protocol

The one-compound rule: If this is your first protocol, run one compound before stacking a second. It's the only way to know which one is actually responsible for an effect, good or bad.

How to Choose a Protocol by Goal

Start from the goal, not the compound.

Goal Common compounds Typical cycle
Tissue & joint recovery BPC-157, or BPC-157 + TB-500 4–6 weeks, injury-driven
Muscle & body composition CJC-1295/Ipamorelin, or a GH-secretagogue stack 8–12 weeks on, 4 weeks off
Sleep & recovery DSIP, CJC-1295/Ipamorelin 4–8 weeks, reassess
Longevity & cellular repair NAD+, GHK-Cu, Epithalon Ongoing with cycling; see anti-aging guide
Skin & connective tissue GHK-Cu, collagen-adjacent peptides 8–12 weeks, visible change is gradual
Testosterone optimization Kisspeptin-10, Gonadorelin - see TRT alternatives guide Protocol-dependent, lab-guided

If more than one goal applies, pick the primary one and run that protocol first. Add a second compound only once you know how the first behaves for you.

Sample Beginner Protocol Templates

These are common starting points, not personalized dosing advice. Your bodyweight and goal will move the numbers, so use the Protocol Builder for one matched to you.

Protocol Typical dose Frequency Cycle length
BPC-157 (single compound) 250–500mcg 1–2x daily 4–6 weeks
BPC-157 + TB-500 BPC-157 250–500mcg / TB-500 2–2.5mg BPC-157 daily / TB-500 2x weekly 4–6 weeks
CJC-1295 + Ipamorelin 100mcg each 1–2x daily, before bed and/or fasted 8–12 weeks on, 4 off
NAD+ (SubQ) 50–100mg 2–3x weekly Ongoing, see NAD+ protocol guide
GHK-Cu 1–2mg Daily or every other day 8–12 weeks

Build your own protocol instead of guessing

Answer a few questions about your goal and the Protocol Builder matches compounds, dosing, and timing - backed by NIH and PubMed research.

Build My Protocol

Dosing and Reconstitution Basics

Most peptides ship as freeze-dried powder and need to be mixed with bacteriostatic water before injection. Getting the concentration right matters, it's the difference between a 250mcg dose and an accidental 2.5mg one. Full details are in the Dosing Guide, and the Dosage Calculator does the math for you. Quick version:

How Long Should a Protocol Run Before Cycling Off?

Cycle length depends on the compound, not one universal rule:

Why cycle at all: A scheduled break gives receptors a rest and creates a natural point to ask whether the protocol is still worth running. If you can't answer why you're still on it, that's the signal to pause.

Why Tracking Your Protocol Matters

A protocol without a log is just a habit. Tracking dose, timing, and how you feel each week turns "I think this is working" into an actual answer, and it's the best way to catch a side effect early. This applies whether you track on paper or in an app. The Protocol Builder and Rate My Stack exist because most people quit paper tracking within a few weeks. If you already have a stack running informally, Rate My Stack will score it in a couple of minutes.

Safety, Sourcing, and Legal Status

Regulatory status depends on the compound. A few peptides are FDA-approved prescription drugs, like Tesamorelin (Egrifta) and Bremelanotide (Vyleesi, sold separately from the unapproved "PT-141" research chemical). Most compounds discussed here, including BPC-157 and TB-500, are sold as unapproved research chemicals. Check each one's status on its page in the Peptide Encyclopedia before sourcing anything.

Research context: Fosgerau K, Hoffmann T. "Peptide therapeutics: current status and future directions." Drug Discovery Today, 2015 - a widely cited overview of peptide pharmacology, delivery, and regulatory status for peptide-based compounds. Search current literature at PubMed and active trials at ClinicalTrials.gov.
Bottom line

Pick one goal, run one compound, track everything.

The protocols that work are boring: one goal, one compound to start, a set dose and schedule, a real stop point, and a log you actually keep. Add complexity later, once you know how the first compound behaves for you. Skipping straight to a five-compound stack with no tracking is the most common beginner mistake here, not the compound choice itself.

My Protocol

I run my own stack the way this guide describes: one goal at a time, tracked. Right now that's BPC-157 and TB-500 for recovery, NAD+ for general support, and Sermorelin, alongside regular training and a clean diet. I built BioStackIQ to actually see whether a protocol like this is working, not just whether I'm sticking to it.

Starting your first protocol? Use the Protocol Builder. Already running a stack? Rate My Stack will score it in a couple of minutes.

Frequently Asked Questions

What is a peptide protocol?

A structured plan for using one or more peptides toward a specific goal, defined by compound, dose, frequency, and cycle length. The protocol is the plan - not just the substance.

How do I choose the right peptide protocol for me?

Start from your goal, not the compound. Match the goal to a compound category first (recovery, GH support, longevity, testosterone optimization), then work out dose, frequency, and cycle length for that specific compound.

How long should a peptide protocol run before cycling off?

Most beginner protocols run 4 to 8 weeks on with a 2 to 4 week break, though GH secretagogues are commonly run 8 to 12 weeks and healing peptides are often used for a defined injury-recovery window instead.

What's a good beginner peptide protocol?

A single-compound protocol focused on one clear goal - commonly BPC-157 alone at 250–500mcg once or twice daily for 4 to 6 weeks - so any effect can actually be attributed to that one compound.

Do I need to track a peptide protocol, or can I just take it?

Tracking is what turns a protocol into data instead of a guess - it's the only reliable way to know if it's working and to catch a side effect early.

Are peptide protocols legal?

It depends on the specific compound. A few are FDA-approved prescription drugs; most discussed in biohacking contexts are sold as unapproved research chemicals. Check each compound's status individually.

How many peptides can I stack in one protocol?

There's no fixed limit, but more compounds means more variables. Most experienced users build up from one compound to a two- or three-compound stack only after learning how the first one behaves for them.

References

Fosgerau K, Hoffmann T. "Peptide therapeutics: current status and future directions." Drug Discovery Today. 2015.
U.S. Food & Drug Administration - fda.gov, for approval and compounding status of specific peptides.